EC Healthcare (HK:2138) has released an update.
EC Healthcare has reported a revenue increase of 8.7% year-on-year to HK$ 4.21 billion for the financial year ending March 31, 2024, driven by strong growth in its aesthetic medical and beauty and wellness segments. However, the company faced a significant net profit drop by 85.3% to HK$ 15.7 million, with basic and diluted earnings per share falling drastically to a loss of 1.6 HK cents. This financial performance reflects increased costs and investments, overshadowing the revenue growth.
For further insights into HK:2138 stock, check out TipRanks’ Stock Analysis page.
